ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1620

Correlation Between Histopathological Findings and PET-CT Results in Patients With Inflammatory Aortitis

Guillem Verdaguer Faja1, rafeal Benito-Melero2, Ignasi Espadaler Fabregó1, Laura López Vilaró1, Mónica Velasco Nuño1, Antonio José Barros Membrilla1, Susana Fernández Sánchez3, Jaime-Félix Dilmé Muñóz1, Ivan Castellvi4, Berta Magallares5, Hye Sang Park1, Asier García-Alija6, Albert Casals Urquiza3, Ana Laiz3, Cesar Diaz-Torne1, Jose Luis Tandaipan7, Luis Sainz Comas1, Helena Codes Mendez3, Júlia Bernardez Moreno8, Carla Marco-Pascual1, Concepción Pitarch3, Andrea Garcia3, Núria Fernández3, Lorena Úbeda3 and Hector Corominas8, 1Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2MD, barcelona, Spain, 3Sant Pau Hospital, Barcelona, Spain, 4Hospital Universitari de la Santa Creu i Sant Pau, Sant Just Desvern, Spain, 5Hospital de Sant Pau, Bareclona, 6Sant Pau Hospital, Barcelona, Catalonia, Spain, 7Hospital de la Santa Creu i Sant Pau, Terrassa, Spain, 8Hospital de Sant Pau, Barcelona, Spain

Meeting: ACR Convergence 2025

Keywords: Imaging, surgery, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1612–1632) Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Inflammatory aortitis is an uncommon condition that can be associated with rheumatologic, neoplastic, or infectious diseases. GCA and isolated aortitis are the most common causes. Although diagnosis is typically based on a combination of clinical, laboratory, and imaging findings—with PET-CT being a key tool in evaluating active inflammatory processes—it is often underdiagnosed prior to surgery, and the diagnosis of aortitis is frequently made only after pathological confirmation. Current literature includes few studies that specifically examine the relationship between preoperative PET-CT results and histopathological findings in patients with inflammatory aortitis.ObjectiveTo analyze the relationship between histopathological findings and preoperative PET-CT results in patients with biopsy-confirmed inflammatory aortitis or those under rheumatology follow-up.

Methods: Between 2020 and 2023, a total of 188 surgical procedures for aortic pathology were performed at our hospital. Cases were selected if they met at least one of the following criteria: (1) identification of an inflammatory pattern based on the standards of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology, or (2) active follow-up for a diagnosis of aortitis by the Rheumatology Department. A total of 37 cases met the inclusion criteria. From this cohort, we selected patients who had undergone PET-CT prior to surgery and tissue sampling.

Results: Five patients with a confirmed diagnosis were included: one with GCA, one with peripheral SpA, one with isolated aortitis, one with inflammatory atherosclerotic aneurysm, and one with infectious aortitis. Clinical and demographic characteristics are shown in Table 1. Two patients underwent emergency surgery for acute aortic syndrome. In one case, a PET-CT performed 4 months prior showed aortomegaly without inflammatory signs, and the biopsy confirmed a non-inflammatory degenerative process, despite elevated CRP at the time of both procedures. In the other case, PET-CT performed the day before surgery revealed an aortic aneurysm without signs of vasculitis, while histological analysis showed a lymphoplasmacytic inflammatory infiltrate with associated fibrosis; this patient also had elevated CRP levels. The remaining 3 patients underwent elective surgery for aortic aneurysm. In these cases, PET-CT also showed no signs of inflammation; however, histopathological analysis revealed inflammatory infiltrates in all specimens (Table 2 and Image). In summary, among the cases analyzed, concordance between PET-CT and histopathological findings was observed in only 1 of 5 patients. In 4 patients, PET-CT results were negative, while biopsies demonstrated characteristic inflammatory patterns.

Conclusion: In this sample, a weak correlation was observed between PET-CT findings and histopathology. Some patients with negative PET-CT scans, showing no evidence of increased metabolic activity, exhibited inflammatory patterns on histological analysis. These findings suggest that a significant proportion of patients with negative PET-CT results may still have an underlying vasculitic process.

Supporting image 1Table 1. Clinical and Demographic Characteristics

Supporting image 2Table 2. Correlation Between PET-CT Findings, Histology, and Rheumatologic Diagnosis

Supporting image 3Histopathological sections corresponding to the patients in Table 2. (1) Non-inflammatory medial degeneration with diffuse extracellular mucinous matrix. (2) Lymphoplasmacytic infiltrate and stromal fibrosis in adventitia. (3) Severe calcified arteriosclerosis with chronic lymphoid infiltrate. (4) Non-necrotizing granulomatous inflammation with multinucleated giant cells. (5) Acute neutrophilic infiltrate with adventitial necrosis.


Disclosures: G. Verdaguer Faja: None; r. Benito-Melero: AbbVie/Abbott, 2, 6, Celgene, 2, 6, Eli Lilly, 2, 6, Merck/MSD, 2, 6, Novartis, 2, 6, Pfizer, 2, 6, Roche, 2, 6; I. Espadaler Fabregó: None; L. López Vilaró: None; M. Velasco Nuño: None; A. Barros Membrilla: None; S. Fernández Sánchez: None; J. Dilmé Muñóz: None; I. Castellvi: None; B. Magallares: None; H. Park: None; A. García-Alija: None; A. Casals Urquiza: None; A. Laiz: None; C. Diaz-Torne: None; J. Tandaipan: None; L. Sainz Comas: None; H. Codes Mendez: None; J. Bernardez Moreno: None; C. Marco-Pascual: None; C. Pitarch: None; A. Garcia: None; N. Fernández: None; L. Úbeda: None; H. Corominas: None.

To cite this abstract in AMA style:

Verdaguer Faja G, Benito-Melero r, Espadaler Fabregó I, López Vilaró L, Velasco Nuño M, Barros Membrilla A, Fernández Sánchez S, Dilmé Muñóz J, Castellvi I, Magallares B, Park H, García-Alija A, Casals Urquiza A, Laiz A, Diaz-Torne C, Tandaipan J, Sainz Comas L, Codes Mendez H, Bernardez Moreno J, Marco-Pascual C, Pitarch C, Garcia A, Fernández N, Úbeda L, Corominas H. Correlation Between Histopathological Findings and PET-CT Results in Patients With Inflammatory Aortitis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/correlation-between-histopathological-findings-and-pet-ct-results-in-patients-with-inflammatory-aortitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-histopathological-findings-and-pet-ct-results-in-patients-with-inflammatory-aortitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology